AngioDynamics Reiterates FY27 Outlook; Appoints Eric Honroth President And CEO - Update
(RTTNews) - While reporting financial results for the first quarter on Thursday, medical technology company AngioDynamics, Inc. (ANGO) reiterated its adjusted loss and net sales guidance for the full year 2027, based on its first quarter performance and current outlook for the re
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.